×
AtriCure Goodwill and Intangible Assets 2010-2025 | ATRC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
AtriCure goodwill and intangible assets from 2010 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
View More
AtriCure Goodwill and Intangible Assets 2010-2025 | ATRC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
AtriCure goodwill and intangible assets from 2010 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$220.2B
Boston Scientific (BSX)
$157B
Stryker (SYK)
$154B
EssilorLuxottica (ESLOY)
$136.6B
Medtronic (MDT)
$119.2B
Lonza Group Ag (LZAGY)
$50.3B
Haleon (HLN)
$44.4B
ResMed (RMD)
$40.3B
GE HealthCare Technologies (GEHC)
$35.5B
Agilent Technologies (A)
$34.1B
Terumo (TRUMY)
$25.8B
Koninklijke Philips (PHG)
$25.2B
Insulet (PODD)
$20.4B
Zimmer Biomet Holdings (ZBH)
$19.3B
Baxter (BAX)
$15B
Smith & Nephew SNATS (SNN)
$13.9B
Sunny Optical Technology (SNPTF)
$10.4B
Demant (WILYY)
$8.6B
Bio-Rad Laboratories (BIO)
$7.2B
Lantheus Holdings (LNTH)
$5B
Perrigo (PRGO)
$3.9B
Prestige Consumer Healthcare (PBH)
$3.8B
Haemonetics (HAE)
$3.6B
Envista Holdings (NVST)
$3.5B
Shandong Weigao Medical Polymer (SHWGF)
$3.5B
ICU Medical (ICUI)
$3.2B
LeMaitre Vascular (LMAT)
$1.9B
QuidelOrtho (QDEL)
$1.9B
Acuren (TIC)
$1.4B
Green Thumb Industries (GTBIF)
$1.3B